Covid-19 man­u­fac­tur­ing roundup: Sene­gal looks to get in the man­u­fac­tur­ing mix; As­pen vac­cine ex­ports part of tem­po­rary deal

Amidst an­oth­er wave of Covid-19, Sene­gal is prepar­ing a man­u­fac­tur­ing plant of its own as the coun­try and its con­ti­nent se­vere­ly lag be­hind the rest of the world on vac­ci­na­tion rates.

The In­sti­tut Pas­teur de Dakar has re­ceived $8 mil­lion from Eu­rope, and an­oth­er $3.3 mil­lion from the US De­vel­op­ment Fi­nance Cor­po­ra­tion to build a site with the goal of pro­duc­ing 25 mil­lion dos­es a month by the end of 2022, Time has re­port­ed. But of­fi­cials wor­ry that es­tab­lish­ing the in­fra­struc­ture could be a long way off as a sim­i­lar foot­print in In­dia took near­ly 10 years to build.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER